Learning Objectives:
1) Learners will develop skills and procedures to evaluate the risks associated with polypharmacy in psychiatric treatment, including the identification of potential drug interactions and strategies for safe medication management, including deprescribing when appropriate.
2) Learners will understand the role of non-pharmacological interventions, such as psychotherapy.
3) Learners will recognize and summarize recent breakthroughs in psychopharmacology, including newly approved medications and emerging treatment modalities relevant to various psychiatric disorders.
4) Learners will understand the use of Collaborative Care.
5) Learners will gain the skills to apply pharmacogenomic testing results in practice, so as to personalize medication choices based on individual patient genetic profiles to optimize treatment efficacy and minimize adverse effects.
6) Learners will create evidence-based management strategies for patients with treatment-resistant psychiatric disorders, incorporating both pharmacological and non-pharmacological interventions.
Accreditation Statement:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A CME credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The Missouri Association of Osteopathic Physicians and Surgeons Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients relative to the content of this presentation.
AOA Grievance Policy:
All grievances should be in writing and specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial written response within 30 days of receipt. If a participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.